home / stock / gnpx / gnpx short
Short Information | Genprex Inc. (NASDAQ:GNPX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 187,130 |
Total Actual Volume | 925,509 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 9,357 |
Average Short Percentage | 20.38% |
Is there a GNPX Short Squeeze or Breakout about to happen?
See the GNPX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $1.985 | $1.91 | $1.9923 | $1.8802 | 20,838 | 9,284 | 44.55% |
07-02-2024 | $1.96 | $1.97 | $1.9999 | $1.89 | 20,701 | 3,397 | 16.41% |
07-01-2024 | $1.99 | $1.93 | $2.0691 | $1.88 | 19,869 | 5,882 | 29.6% |
06-28-2024 | $2 | $1.885 | $2.0999 | $1.87 | 40,536 | 9,709 | 23.95% |
06-27-2024 | $1.96 | $1.97 | $2.1983 | $1.91 | 98,903 | 32,784 | 33.15% |
06-26-2024 | $2.13 | $1.96 | $2.165 | $1.93 | 35,594 | 4,338 | 12.19% |
06-25-2024 | $2.04 | $2.04 | $2.1178 | $2.01 | 20,721 | 3,683 | 17.77% |
06-24-2024 | $2.02 | $2.02 | $2.2 | $2.01 | 51,473 | 16,380 | 31.82% |
06-21-2024 | $2.082 | $2.02 | $2.14 | $2.02 | 32,118 | 1,416 | 4.41% |
06-20-2024 | $2.03 | $2.05 | $2.08 | $2.01 | 27,675 | 4,017 | 14.51% |
06-18-2024 | $2.26 | $2.08 | $2.26 | $2.01 | 24,145 | 3,678 | 15.23% |
06-17-2024 | $2.14 | $2.21 | $2.26 | $2.11 | 29,728 | 6,974 | 23.46% |
06-14-2024 | $2.47 | $2.17 | $2.47 | $2.12 | 81,619 | 6,373 | 7.81% |
06-13-2024 | $2.55 | $2.42 | $2.6 | $2.42 | 34,148 | 6,148 | 18% |
06-12-2024 | $2.6199 | $2.59 | $2.6199 | $2.49 | 24,433 | 4,313 | 17.65% |
06-11-2024 | $2.46 | $2.53 | $2.6 | $2.3 | 50,409 | 12,734 | 25.26% |
06-10-2024 | $2.42 | $2.49 | $2.5351 | $2.4 | 36,521 | 5,699 | 15.6% |
06-07-2024 | $2.69 | $2.45 | $2.69 | $2.41 | 90,296 | 23,901 | 26.47% |
06-06-2024 | $2.92 | $2.735 | $2.92 | $2.71 | 66,016 | 11,288 | 17.1% |
06-05-2024 | $2.98 | $2.91 | $3 | $2.74 | 119,766 | 15,132 | 12.63% |
News, Short Squeeze, Breakout and More Instantly...
Genprex Issues Stockholder Letter and Provides 2024 Corporate Update PR Newswire Company Achieves Multiple Clinical Development Milestones in 2024 Patient Treatment Continues in Three Lung Cancer Clinical Trials AUSTIN, Texas , June 27, 2024 /PRNe...
Genprex to Present at the 2024 BIO International Convention PR Newswire Presentation to Highlight the Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas , May 30, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: ...